Abstract
Background Graves’ disease (GD) is an autoimmune hyperthyroidism that primarily affects the thyroid gland. The susceptibility, activity, and risk of recurrence of GD may be influenced by various genetic factors, which can interact with environmental triggers to precipitate disease relapse. This review examines the literature on the genetic predisposition to GD recurrence.
Methods Literature from PubMed, EBSCOhost, and SCOPUS were searched. Three reviewers performed study selection and critical appraisal.
Result Five studies were selected. The literature indicates a risk of relapse in PTPN22, CTLA-4, TSH-R, IL-21, KREC, and HLA gene abnormalities.
Conclusion Several genes are associated with GD relapse. However, predicting relapse risk requires consideration of multiple factors beyond genetic predisposition.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
PROSPERO registration number CRD42024456285
Data Availability
All data produced are available online at MedLine, EBSCOhost and Scopus
